MelvinSpeismanMD

Physician

Dr. Speisman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1801 W. Taylor Street
University of Illinois at Chicago Outpatient Care Center Suite 3AA
Chicago, IL 60612
Phone+1 708-567-1167

Dr. Melvin Speisman is an assistant professor in the Division of Academic Internal Medicine in the Department of Medicine of the University of Illinois at Chicago College of Medicine. He is an expert in the diagnosis and treatment of hypertension, diabetes, congestive heart failure, atrial fibrillation, coronary artery disease, and stroke. He is interested in the primary prevention of disease with a passion for medical education. He has received numerous awards from medical students and residents. Dr. Speisman has mentored many physicians to take on leadership roles in academic internal medicine. He has made a lifelong commitment to research, teaching, and outstanding patient care.

West Suburban Medical CenterChief Residency, Internal Medicine, 1996 - 1997
West Suburban Medical CenterResidency, Internal Medicine, 1995 - 1996
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1993 - 1995
University of Illinois College of MedicineClass of 1993
Northwestern UniversityBA, 1985 - 1989

Abstracts/Posters

Therapeutic Hypothermia After Cardiac Arrest
Jeganathan N, Marinelli A, Speisman M, Murthy V, Meeting of the American Thoracic Society (ATS), San Francisco, California, 5/18/2012

Translational Molecular Research in Congestive Heart Failure Lab of Robert S Decker, PhD Professor of Medicine, Northwestern UniversityEffect of Catecholamines on Cardiac Myocytes: Catecholamines induce an inotropic response in the adult heart. RNA was isolated from cardiac myocytes after exposure to catecholamines and beta blockers. This research defined the molecular mechanisms by which beta blockers reduce mortality in CHF.1993 - 1993
Translational Research in Gastroesophageal Reflux Disease Lab of Thomas J. Layden MD, Chief of Gastroenterology, University of Illinois at Chicago College of MedicineIntracellular pH regulation of esophageal cells: molecular studies were done to demonstrate that esophageal cells have a Na/H antiporter. This research defined molecular basis for effective treatment of gastroesophageal reflux disease. Research mentor was Jay Goldstein MD1989 - 1989